Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies.

Dagfinn Aune, Sabrina Schlesinger, Teresa Norat, Elio Riboli

Journal: European journal of preventive cardiology 2019;25(13):1437-1451

PMID: 29996680

Abstract

Background Epidemiological studies on smoking and atrial fibrillation have been inconsistent, with some studies showing a positive association while others have found no association. It is also unclear whether there is a dose-response relationship between the number of cigarettes smoked or pack-years and the risk of atrial fibrillation. We conducted a systematic review and meta-analysis to clarify the association. Design Systematic review and meta-analysis. Methods We searched the PubMed and Embase databases for studies of smoking and atrial fibrillation up to 20 July 2017. Prospective studies and nested case-control studies within cohort studies reporting adjusted relative risk estimates and 95% confidence intervals (CIs) of atrial fibrillation associated with smoking were included. Summary relative risks (95% CIs) were estimated using a random effects model. Results Twenty nine prospective studies (22 publications) were included. The summary relative risk was 1.32 (95% CI 1.12-1.56, I= 84%, n = 11 studies) for current smokers, 1.09 (95% CI 1.00-1.18, I= 33%, n = 9) for former smokers and 1.21 (95% CI 1.12-1.31, I= 80%, n = 14) for ever smokers compared to never smokers. Comparing current versus non-current smokers the summary relative risk was 1.33 (95% CI 1.14-1.56, I= 78%, n = 10). The summary relative risk was 1.14 (95% CI 1.10-1.20, I= 0%, n = 3) per 10 cigarettes per day and 1.16 (95% CI 1.09-1.25, I= 49%, n = 2) per 10 pack-years and there was no evidence of a non-linear association for cigarettes per day, P = 0.17. Conclusions The current meta-analysis suggests that smoking is associated with an increased risk of atrial fibrillation in a dose-dependent matter, but the association is weaker among former smokers compared to current smokers.

Address: 1 Department of Epidemiology and Biostatistics, Imperial College London, UK.; 2 Department of Nutrition, Bjørknes University College, Norway.; 3 Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Norway.; 4 Institute for Biometry and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.